Ton Lisman

Q: What Schools Are Affiliated With Ton Lisman

Ton Lisman is affiliated with the following schools: University of Amsterdam, Utrecht University, University of Groningen, Eindhoven University of Technology, Delft University of Technology, Leiden University

Ton Lisman's AcademicInfluence.com Rankings

Ton Lisman

Computer Science

#6519

World Rank

#6872

Historical Rank

Machine Learning

#2143

World Rank

#2171

Historical Rank

Artificial Intelligence

#2405

World Rank

#2446

Historical Rank

Database

#3597

World Rank

#3748

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Ton Lisman's Degrees

PhD Computer Science Delft University of Technology
Masters Artificial Intelligence University of Amsterdam
Bachelors Computer Science University of Amsterdam

Similar Degrees You Can Earn

Why Is Ton Lisman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ton Lisman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. (2010) (540)
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity (2006) (519)
Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management (2006) (466)
Hemostasis and thrombosis in patients with liver disease: the ups and downs. (2010) (324)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. (2010) (313)
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1 (2006) (286)
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. (2001) (285)
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. (2004) (271)
Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers (2012) (255)
Haemostatic abnormalities in patients with liver disease. (2002) (222)
Platelet Transfusion During Liver Transplantation Is Associated with Increased Postoperative Mortality Due to Acute Lung Injury (2009) (216)
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. (2012) (215)
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis (2005) (215)
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. (2010) (205)
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases (2020) (188)
Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death (2017) (176)
Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. (2008) (174)
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. (2002) (165)
Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment (2007) (164)
Criteria for Viability Assessment of Discarded Human Donor Livers during Ex Vivo Normothermic Machine Perfusion (2014) (162)
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome (2013) (151)
Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease (2017) (139)
The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration (2001) (132)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference (2018) (128)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference (2018) (128)
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial (2020) (124)
Immediate Postoperative Low Platelet Count is Associated With Delayed Liver Function Recovery After Partial Liver Resection (2010) (120)
A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. (2006) (117)
Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis (2008) (115)
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. (2003) (115)
Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A (2007) (115)
Protection of Bile Ducts in Liver Transplantation: Looking Beyond Ischemia (2011) (113)
Hemostasis in liver disease: implications of new concepts for perioperative management. (2014) (113)
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report (2020) (113)
Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. (2014) (112)
Platelet adhesion to dimeric β2‐glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibα and apolipoprotein E receptor 2′ (2007) (111)
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation (2020) (110)
Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death (2014) (108)
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. (2013) (107)
Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure (2012) (106)
Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers (2019) (106)
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 (2020) (101)
Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen (2016) (100)
Bleeding in liver surgery: prevention and treatment. (2009) (99)
Mechanism of action of recombinant factor VIIa (2003) (98)
Platelets in liver transplantation: Friend or foe? (2008) (97)
Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding (2014) (94)
Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers (2016) (93)
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis (2014) (90)
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count (2005) (89)
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases (2017) (88)
Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? (2009) (87)
Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation. (2015) (87)
Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. (2019) (86)
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. (2010) (85)
Routine coagulation assays underestimate levels of antithrombin‐dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis (2013) (83)
Normothermic machine perfusion of donor livers without the need for human blood products (2018) (81)
Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. (2006) (80)
Interlaboratory variability in assessment of the model of end‐stage liver disease score (2008) (79)
Hypofibrinolysis is a risk factor for arterial thrombosis at young age (2009) (78)
The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. (2008) (78)
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. (2007) (78)
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial (2013) (76)
Rebalanced Hemostasis in Patients with Acute Liver Failure (2015) (75)
Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation (2002) (74)
Balanced haemostasis with both hypo‐ and hyper‐coagulable features in critically ill patients with acute‐on‐chronic‐liver failure (2018) (74)
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux (2003) (74)
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation (2004) (73)
The two tales of coagulation in liver transplantation (2008) (72)
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men (2009) (71)
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge (2021) (69)
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient (2013) (67)
The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions (2010) (67)
The role of platelets in liver inflammation and regeneration. (2010) (67)
Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens. (2008) (67)
Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors (2015) (66)
Development of a Severe von Willebrand Factor/ADAMTS13 Dysbalance During Orthotopic Liver Transplantation (2009) (65)
Preserved hemostatic status in patients with non-alcoholic fatty liver disease. (2016) (64)
The impact of the fibrinolytic system on the risk of venous and arterial thrombosis. (2009) (63)
Staphylococcal superantigen‐like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibα and αIIbβ3 (2009) (62)
End‐ischemic machine perfusion reduces bile duct injury in donation after circulatory death rat donor livers independent of the machine perfusion temperature (2015) (61)
No evidence for an intrinsic platelet defect in patients with liver cirrhosis – studies under flow conditions (2006) (60)
INJURY OF PERIBILIARY GLANDS AND VASCULAR PLEXUS BEFORE LIVER TRANSPLANTATION PREDICTS FORMATION OF NON-ANASTOMOTIC BILIARY STRICTURES (2014) (59)
β2-Glycoprotein I Is Proteolytically Cleaved In Vivo upon Activation of Fibrinolysis (1999) (59)
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. (2022) (58)
Alterations in Fibrin Structure in Patients with Liver Diseases (2016) (58)
The platelet and platelet function testing in liver disease. (2009) (58)
Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure. (2016) (57)
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI‐antigen levels, clot lysis time and the risk of venous thrombosis (2006) (56)
Mechanisms of the Factor V Leiden Paradox (2008) (55)
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival (2019) (55)
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality (2020) (54)
Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment (2012) (53)
Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis (2016) (53)
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis (2015) (51)
Mechanisms of platelet-mediated liver regeneration. (2016) (51)
Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers (2016) (51)
Towards a rational use of low‐molecular‐weight heparin in patients with cirrhosis (2011) (50)
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men (2009) (50)
Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: results of point of care testing with the thromboelastography analyser (2009) (50)
The impact of hepatic steatosis on liver regeneration after partial hepatectomy (2013) (49)
Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients (2006) (49)
Platelet aggregation: involvement of thrombin and fibrin(ogen). (2005) (48)
Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. (2019) (48)
Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis (2019) (48)
Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis (2003) (47)
Role of Fibrin Sealants in Liver Surgery (2012) (46)
Fibrinolysis and the risk of venous and arterial thrombosis (2007) (44)
The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease (2021) (43)
How to minimize blood loss during liver surgery in patients with cirrhosis. (2009) (43)
Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1. (2008) (42)
Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. (2017) (42)
Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome (2010) (41)
Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions. (2014) (41)
Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis (2005) (40)
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors. (2021) (39)
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia (2009) (38)
Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy (2012) (37)
Perioperative hemostatic management in the cirrhotic patient: a position paper on the behalf of the Liver Intensive Care Group of Europe (LICAGE). (2019) (36)
Prohemostatic Interventions in Liver Surgery (2012) (36)
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? (2015) (36)
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. (2012) (35)
Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. (2019) (35)
Transient von Willebrand factor‐mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice (2017) (35)
Reversal of hypercoagulability in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals (2018) (35)
Hypercoagulability following major partial liver resection ‐ detected by thrombomodulin‐modified thrombin generation testing (2015) (34)
Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury (2012) (34)
Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor (2003) (34)
Hepatic artery thrombosis after liver transplantation: more than just a surgical complication? (2009) (33)
Peribiliary Glands Are Key in Regeneration of the Human Biliary Epithelium After Severe Bile Duct Injury (2019) (33)
Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease (2010) (33)
Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis (2014) (33)
In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis (2018) (33)
Duct‐to‐duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy (2014) (32)
Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow‐up study (2010) (32)
Glycoprotein Ibα–Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin Under Conditions of Flow (2005) (32)
Platelets as Modulators of Liver Diseases (2017) (31)
Oxygenated hypothermic machine perfusion after static cold storage improves endothelial function of extended criteria donor livers. (2016) (31)
The combination of primary sclerosing cholangitis and CCR5‐Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation (2011) (30)
Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. (2010) (30)
Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation. (2004) (30)
A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. (2008) (29)
Evaluation of hemostasis in patients with end-stage renal disease (2019) (29)
Circulating endothelial cells in cancer patients do not express tissue factor. (2004) (29)
Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy. (2005) (28)
Thromboelastography does not predict outcome in different etiologies of cirrhosis (2017) (28)
Ex Situ Normothermic Machine Perfusion of Donor Livers. (2015) (28)
Repopulating the biliary tree from the peribiliary glands. (2017) (27)
Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice. (2020) (27)
Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A (2003) (27)
Elevated Plasma Levels of Cell‐Free DNA During Liver Transplantation Are Associated With Activation of Coagulation (2018) (27)
Prediction of bleeding in cirrhosis patients: Is the forecast any clearer? (2016) (26)
Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours (2020) (26)
Activation of hemostasis in brain dead organ donors: an observational study (2011) (26)
Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease (2020) (26)
Cirrhosis as a risk factor for venous thrombosis (2016) (26)
Activation of Fibrinolysis, But Not Coagulation, During End-Ischemic Ex Situ Normothermic Machine Perfusion of Human Donor Livers (2017) (25)
VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure (2020) (25)
Fibrinolytic Proteins in Human Bile Accelerate Lysis of Plasma Clots and Induce Breakdown of Fibrin Sealants (2012) (25)
Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case–control study (2012) (24)
Management of coagulation abnormalities in liver disease (2015) (24)
Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis. (2020) (23)
Thrombin Generation and Cirrhosis: State of the Art and Perspectives (2020) (23)
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis (2020) (23)
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. (2011) (23)
Decreased tissue factor pathway inhibitor (TFPI)‐dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels (2013) (22)
Hemostasis in chronic liver disease (2006) (22)
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus (2021) (22)
The influence of the pulsatility of the blood flow on the extent of platelet adhesion. (2008) (22)
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. (2011) (22)
Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy (2016) (22)
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. (2015) (22)
Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial) (2019) (21)
Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation (2015) (21)
Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential (2017) (21)
Hemostatic Dysfunction in Liver Diseases (2015) (20)
Transmission of idiopathic thrombocytopenic purpura during orthotopic liver transplantation (2009) (20)
Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease (2020) (19)
Rebuttal to: Effect of heparin on TAFI‐dependent inhibition of fibrinolysis (2003) (19)
Inflammation Mediated Down-Regulation of Hepatobiliary Transporters Contributes to Intrahepatic Cholestasis and Liver Damage in Murine Biliary Atresia (2009) (19)
Platelets and fibrin in progression of liver disease: friends or foes? (2015) (19)
Antiplatelet medication after liver transplantation: Does it affect outcome? (2007) (19)
Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. (2015) (18)
Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa (2013) (18)
Reply to: "Procoagulant imbalance in patients with non-alcoholic fatty liver disease". (2017) (18)
Platelet function in patients with cirrhosis. (2012) (17)
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF (2019) (17)
Methodological issues with coagulation testing in patients with liver disease. (2006) (17)
Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients (2021) (17)
Is chronic liver disease associated with a bleeding diathesis? (2006) (17)
Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival (2014) (17)
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. (2022) (17)
Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. (2004) (17)
Mechanisms of enhanced thrombin‐generating capacity in patients with cirrhosis (2018) (17)
Oxygen Transport during Ex Situ Machine Perfusion of Donor Livers Using Red Blood Cells or Artificial Oxygen Carriers (2020) (16)
Evidence against a role of serotonin in liver regeneration in humans (2015) (16)
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma (2015) (16)
The cirrhotic platelet: Shedding light on an enigma (2017) (16)
TAFI deficiency promotes liver damage in murine models of liver failure through defective down-regulation of hepatic inflammation (2013) (16)
Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures (2014) (16)
Platelet‐leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion (2018) (15)
Safety of direct oral anticoagulants in patients with advanced liver disease (2021) (15)
The role of platelets in liver regeneration - What don't we know? (2015) (15)
Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome (2021) (15)
Prothrombotic Gene Polymorphisms: Possible Contributors to Hepatic Artery Thrombosis After Orthotopic Liver Transplantation (2011) (15)
Intact thrombomodulin‐mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin‐mediated regulation of coagulation (2010) (15)
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease (2020) (15)
Tissue factor-independent effects of recombinant factor VIIa on hemostasis. (2008) (14)
Consequences of abnormal hemostasis tests for clinical practice. (2006) (14)
Pitfalls in assessing platelet activation status in patients with liver disease (2012) (14)
No evidence for systemic platelet activation during or after orthotopic liver transplantation (2009) (14)
Von Willebrand factor deficiency reduces liver fibrosis in mice (2017) (14)
Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (14)
Management of Hemostatic Disorders in Patients With Advanced Liver Disease Admitted to an Intensive Care Unit. (2017) (13)
Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice (2015) (13)
Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure (2021) (13)
The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa. (2015) (13)
Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease (2015) (12)
No increased systemic fibrinolysis in women with heavy menstrual bleeding (2014) (12)
Production of Physiologically Relevant Quantities of Hemostatic Proteins During Ex Situ Normothermic Machine Perfusion of Human Livers (2018) (12)
Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay (2020) (12)
Treatment of bleeding in patients with liver disease (2021) (11)
DEVELOPMENT OF A SEVERE VON WILLEBRAND FACTOR/ADAMTS13 DYSBALANCE DURING ORTHOTOPIC LIVER TRANSPLANTION - A POSSIBLE RISK FOR POST-OPERATIVE THROMBOSIS? (2009) (11)
“Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply (2021) (11)
Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study (2019) (11)
Haemostatic alterations and management of haemostasis in patients with cirrhosis. (2022) (10)
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study (2018) (10)
Sustained pro-haemostatic activity of rFVIIa in plasma and platelets in non-bleeding pigs may explain the efficacy of a once-daily prophylaxis in humans (2014) (10)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease : Proceedings of the 7 th International Coagulation in Liver Disease Conference October 6 th and 7 th , 2017 Rome , Italy (2018) (10)
Nails in the coffin of fresh frozen plasma to prevent or treat bleeding in cirrhosis? (2019) (10)
Anemia as a potential contributor to bleeding in patients with liver disease - Neglected but not forgotten (2011) (10)
Hemostatic issues in pregnancy-induced liver disease. (2017) (10)
Extrahemostatic Functions of Platelets and Coagulation Factors (2018) (10)
COVID-19 is Associated with an Acquired Factor XIII Deficiency (2021) (10)
A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. (2016) (10)
Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation – a retrospective study (2019) (9)
In vitro effects of proteases in human pancreatic juice on stability of liquid and carrier‐bound fibrin sealants (2013) (9)
Mechanism of Action of Recombinant Activated Factor VII (2003) (9)
Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors (2018) (9)
Differentiating biochemical from clinical heparin resistance in COVID-19 (2020) (9)
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al. (2021) (9)
Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteers. (2020) (8)
Anticoagulant activity of edoxaban in patients with cirrhosis. (2020) (8)
The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders (2016) (8)
Detection and localization of early- and late-stage cancers using platelet RNA. (2022) (8)
Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation (2020) (8)
Hemostasis in patients with liver disease. (2009) (7)
SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS (2008) (7)
Routine Postoperative Antithrombotic Therapy in Pediatric Liver Transplantation: Impact on Bleeding and Thrombotic Complications (2020) (7)
Platelet Function in Stored Heparinised Autologous Blood Is Not Superior to in Patient Platelet Function during Routine Cardiopulmonary Bypass (2012) (7)
Hemostatic Complications in Hepatobiliary Surgery (2017) (7)
Development of a hypercoagulable status in patients undergoing off-pump lung transplantation despite prolonged conventional coagulation tests. (2015) (7)
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease. (2017) (7)
Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality (2021) (7)
The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis (2020) (7)
Letter by Hugenholtz and Lisman regarding article, "plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy". (2015) (7)
Systematic comparison of routine laboratory measurements with in-hospital mortality: ICU-Labome, a large cohort study of critically ill patients (2018) (7)
Decreased Fibrinolytic Capacity in Cirrhosis and Liver Transplantation Outcomes (2019) (7)
Dual Versus Single Oxygenated Hypothermic Machine Perfusion of Porcine Livers: Impact on Hepatobiliary and Endothelial Cell Injury (2021) (7)
Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood. (2012) (7)
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report". (2021) (7)
The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study (2022) (6)
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation (2014) (6)
Issues with monitoring of unfractionated heparin in cirrhosis. (2015) (6)
Blood Markers of Portal Hypertension Are Associated with Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation (2020) (6)
The interaction of recombinant factor VIIa with platelet glycoprotein Ib. (2010) (6)
Coagulation activation during air travel is not initiated via the extrinsic pathway (2015) (6)
Decreased plasma levels of activated factor VII in patients with deep vein thrombosis (2015) (6)
Genome scan of clot lysis time and its association with thrombosis in a protein C‐deficient kindred (2011) (6)
Fibrinolysis in Patients with Liver Disease (2021) (6)
Severe Prolongation of the INR in Spur Cell Anemia of Cirrhosis: True-True and Related? (2006) (6)
The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations (2012) (5)
Activation of Coagulation by Living Donor Kidney Transplants Early After Reperfusion (2010) (5)
Plasma molecules predicting liver dysfunction following partial hepatectomy are not only derived from platelet α‐granules (2016) (5)
Low molecular weight heparin in management and prevention of portal vein thrombosis. (2014) (5)
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease. (2022) (5)
Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities. (2011) (4)
Fibrin fuels fatty liver disease (2018) (4)
In vitro uptake of recombinant factor VIIa by megakaryocytes with subsequent production of platelets containing functionally active drug (2017) (4)
Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference (2019) (4)
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans (2021) (4)
Long-term normothermic machine preservation of human livers: What is needed to succeed? (2021) (4)
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation (2021) (4)
Evidence against a role for platelet-derived molecules in liver regeneration after partial hepatectomy in humans (2016) (3)
Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (F2) gene mutation in a Dutch Caucasian family with unexplained thrombosis (2020) (3)
Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation (2020) (3)
O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels. (2006) (3)
Development of a Hyperactive Primary Hemostatic System During Off‐Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13 (2015) (3)
Heparin – Messias or Verschlimmbesserung? (2021) (3)
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. (2014) (3)
Intact Thrombin Generation and Decreased Fibrinolytic Capacity in Patients with Acute Liver Failure Argue Against Routine Prophylactic Correction of Coagulation Prior to Liver Transplantation (2012) (3)
Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer. (2020) (3)
Author response to Letter to the Editor: ‘AB0, von Willebrand factor/Factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?’ (2020) (3)
Nanomedicine in Thrombosis and Hemostasis: The Future of Nanotechnology in Thrombosis and Hemostasis Research and Clinical Applications (2020) (3)
Sustained prothrombotic changes in convalescent patients with COVID-19 (2021) (3)
Fibrinolysis in liver disease (2012) (3)
ACUTE LIVER INJURY/FAILURE (ALI/ALF) RESULTS IN BALANCED HEMOSTASIS DESPITE ELEVATED INR (2010) (3)
Hypofibrinolysis as a Risk Factor for Venous Thrombosis. (2006) (3)
In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation (2020) (3)
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites (2021) (3)
Acquired bleeding disorders (2022) (3)
Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease (2017) (3)
Bleeding and Thrombosis in Patients with Liver Diseases (2020) (3)
ID: 199 Binding of TAFI to collagen: a role for TAFI in the regulation of platelet adhesion? (2006) (3)
Factor XI binding to platelets: glycoprotein Ib alpha has an accomplice. (2009) (3)
GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE (2007) (3)
Efficacy of pro‐ and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery (2020) (3)
Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis (2021) (3)
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (3)
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. (2021) (2)
Normothermic machine perfusion of donor livers using a novel hemoglobin based oxygen carrier solution, eliminating the need for human blood products (2016) (2)
Acquired bleeding disorders (2020) (2)
Response to "The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis". (2020) (2)
Hemostasis and Thrombosis in Extreme Physiological and Pathological Conditions (2018) (2)
Fresh frozen plasma in treating acute variceal bleeding: Not effective and likely harmful (2021) (2)
A mechanism to safeguard platelet adhesion under high‐shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen‐type‐specific contributions to adhesion: a rebuttal (2007) (2)
Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII (2022) (2)
Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. (2017) (2)
Understanding and Managing the Coagulopathy of Liver Disease (2019) (2)
Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin (2019) (2)
Plasma levels of Midkine (neurite growth‐promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis (2012) (2)
Thromobcytopenia is Associated with Multi-organ System Failure in Patients With Acute Liver Failure (2017) (2)
Therapeutic anticoagulation after liver transplantation is not useful among patients with pre‐transplant Yerdel‐grade I/II portal vein thrombosis: A two‐center retrospective study (2021) (2)
Hemostasis in chronic liver disease (2006) (2)
Assessing in vivo platelet activation in patients with liver diseases (2016) (2)
Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome (2021) (2)
Changes in cholangiocyte bile salt transporter expression and bile duct injury after orthotopic liver transplantation (2010) (2)
Anticoagulant Management and Synthesis of Hemostatic Proteins during Machine Preservation of Livers for Transplantation (2020) (2)
Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome‐wide association study (2021) (2)
Hemostatic and Non-hemostatic Functions of Platelets in Patients with Liver Disease (2017) (2)
Recombinant factor VIIa improves clot formation but not tafi-mediated downregulation of fibrinolysis in patients with cirrhosis and during liver transplantation. (2001) (2)
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates (2021) (2)
University of Groningen Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease faculty of the 7th International Coagulation in Liver Disease (2018) (2)
Anticoagulation in thrombocytopenic patients – Time to rethink? (2022) (2)
Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges (2021) (1)
Recombinant Factor VIIa Enhances Platelet Adhesion and Aggregation under Flow Conditions at Normal and Reduced Platelet Count. (2004) (1)
The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease (2019) (1)
Hemostatic Changes of Acute Kidney Injury in Patients With Cirrhosis: What Do They Mean? (2020) (1)
Staphylococcal Superantigen-Like 5 Activates Platelets, and Supports Platelet Adhesion Under Flow Conditions, Which Is Mediated by GPIb-Alpha and Alpha-IIb-Beta-3 (2008) (1)
Serum gamma glutamyl transpeptidase levels post-liver transplantation and survival data (2014) (1)
P1076 : Non-alcoholic fatty liver disease is not associated with plasma hypercoagulability (2015) (1)
Coagulation and Blood Transfusion Management (2012) (1)
Global assays of fibrinolysis (2017) (1)
M1007 Hepatobiliary Transport Regulation in the Development of Murine Biliary Atresia (2009) (1)
Anticoagulation in Pediatric Liver Transplantation; the Pros and Cons. (2018) (1)
Physiology, Prevention, and Treatment of Blood Loss During Liver Transplantation (2012) (1)
Hypothermic Oxygenated Machine Preservation of Livers from Donation after Cardiac Death: Does It Reduce Bile Duct Injury? (2012) (1)
Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease (2021) (1)
Tranexamic Acid Is Not a Universal Hemostatic Agent (2021) (1)
SAT-017-Anticoagulant effect of edoxaban in patients with cirrhosis: The POET study (2019) (1)
Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor (2021) (1)
Hemostasis in chronic liver disease (2006) (1)
Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thrombelastometry and Cryoprecipitate Transfusion. (2021) (1)
Lower-leg injury and knee arthroscopy have distinct effects on coagulation (2022) (1)
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis (2008) (1)
Pathophysiology and management of bleeding and thrombosis in patients with liver disease (2022) (1)
Antithrombotic Management in Adult Kidney Transplantation: A European Survey Study (2021) (1)
Normothermic Oxygenated Machine Preservation Reduces Reperfusion Injury of DCD Livers but Seems Less Useful in DBD Livers (2013) (1)
Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: “Acute Liver Failure in Children”: Treatment and Directions for Future Research (2021) (1)
Database containing demographic data of each patient and laboratory data of each patient and control (2014) (1)
Platelet transfusion during liver transplantation is associated with postoperative mortality due to acute lung injury (2008) (1)
Recombinant factor VIIa reverses the anticoagulant and profibrinolytic effect of the synthetic pentasaccharide ORG31540/SR90107A in vitro (2001) (1)
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis (2023) (1)
Normothermic Oxygenated Machine Preservation Reduces Reperfusion Injury of DCD Livers but Seems Less Useful in Standard Heart-Beating Livers : A Comparative Study in a Rat Model (2013) (0)
APROTININ INHIBITS THROMBIN GENERATION BY THE INTRINSIC PATHWAY OF COAGULATION, BUT IS NOT A DIRECT THROMBIN INHIBITOR (2021) (0)
Response to the role of platelets on regenerating liver: Thoughts beyond parenchymal proliferation (2017) (0)
Hemostatic Problems in Chronic and Acute Liver Disease (2014) (0)
Three strikes to a hemophilic joint bleed. (2018) (0)
Reply to: Platelet function in patients with cirrhosis (2012) (0)
Fibrin clot properties and thrombus composition in cirrhosis (2023) (0)
Histological Analysis of Donor Lung Derived Thrombi (2021) (0)
Biochemical Composition of Perfusion Fluid Used For Normothermic Machine Perfusion of Donor Livers. (2014) (0)
PF803 VON WILLEBRAND FACTOR DELAYS LIVER REPAIR AFTER ACETAMINOPHEN-INDUCED ACUTE LIVER INJURY IN MICE (2019) (0)
Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients. (2022) (0)
No increased fibrinolysis in women with menorrhagia (2013) (0)
Pre- and postconditioning effects of metformin in rat donor livers (2016) (0)
The portal vein in patients with cirrhosis is not an extensively inflammatory or hypercoagulable vascular bed (2022) (0)
independent fibrin generation - platelets via tissue factor 3-deficient β IIb α Recombinant factor VIIa restores aggregation of (2013) (0)
Treatment and prevention of portal vein thrombosis in patients with cirrhosis (2021) (0)
RESTRICTIVE USE OF BLOOD PRODUCTS DURING LIVER TRANSPLANTATION (2009) (0)
Increase in RBC Transfusion Requirements during Orthotopic Liver Transplantation after Market Withdrawal of Aprotinin. (2013) (0)
University of Groningen Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis Potze, (2014) (0)
Tissue-type plasminogen activator in human bile results in accelerated lysis of plasma clots or fibrin sealants (2010) (0)
313.7: Hypothermic Machine Perfusion Ameliorates Fibrinolysis And Microthrombi Clearance After DCD Kidney Donation (2022) (0)
Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease (2015) (0)
Molecular mechanisms of platelet-mediated liver regeneration after partial hepatectomy (2017) (0)
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation (2013) (0)
Elevated plasma levels of cell-free DNA during orthotopic liver transplantation are associated with activation of coagulation. (2019) (0)
The anti-coagulants ASIS or APC do not protect against renal ischemia/ reperfusion injury (2014) (0)
Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites (2019) (0)
Markers of neutrophil extracellular traps are associated with poor outcome in patients with acute liver failure (2020) (0)
P1074 : No evidence for platelet hyperactivity in patients with non-alcoholic fatty liver disease (2015) (0)
Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure. (2023) (0)
The glycoprotein Ib-DC-V complex contributes to tissue factor-independent thrombin generation by recombinant factor Vila on the activated platelet surface. Commentaty (2008) (0)
COAGULATION PROTEIN PROFILE OF STABLE PEDIATRIC RECIPIENTS OF AN ADULT LIVER GRAFT INDICATES THAT PLASMA LEVELS OF COAGULATION PROTEINS ARE NOT REGULATED BY THE LIVER (2010) (0)
Platelets play an important role in the recovery of liver dysfunction after hepatic resection. (2010) (0)
FIBRINOLYTIC PROTEINS PRESENT IN HUMAN BILE RESULT IN ACCELERATED LYSIS OF PLASMA CLOTS OR FIBRIN SEALANTS (2010) (0)
Hemostatic profiles in liver disease: novel evidence of mixed phenotype in critically-ill patients with cirrhosis and liver failure and implications for clinical management of hemostatic disturbance. (2015) (0)
Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study. (2022) (0)
A REBALANCED HEMOSTATIC SYSTEM IN PEDIATRIC PATIENTS UNDERGOING LIVER TRANSPLANTATION : A PROSPECTIVE COHORT STUDY (2019) (0)
Circulating cell-free DNA levels increment with worsening cirrhosis severity and associate with platelet exhaustion and mortality (2022) (0)
NO EVIDENCE FOR SUBSTANTIAL SYSTEMIC ACTIVATION OF BLOOD PLATELETS DURING ORTHOTOPIC LIVER TRANSPLANTATION (2008) (0)
P-040 No increased fibrinolysis in women with menorrhagia (2013) (0)
Factor VIII/protein C ratio does not reflect coagulation but is linked to pathophysiological mechanisms driving disease progression in patients with advanced chronic liver disease (2022) (0)
Hypothermic oxygenated machine perfusion enables 24-hour Ex situ preservation of porcine donation after circulatory death livers (2020) (0)
Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure (2022) (0)
Anticoagulation to prevent disease progression in patients with cirrhosis. (2023) (0)
Reply to: Correspondence on "Predicting portal thrombosis in cirrosis: A prospective study of clinical, ultrasonographic and hemostatic factors". (2021) (0)
Global hemostatic status in patients with acute-on-chronic liver failure and patients with sepsis without underlying liver disease (2020) (0)
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature. (2023) (0)
Fibrin fixes fibrosis. (2016) (0)
Hemostatic Disorders and the Liver (2021) (0)
Faculty Opinions recommendation of Activation peptides prolong the murine plasma half-life of human factor VII. (2011) (0)
Faculty Opinions recommendation of Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. (2012) (0)
SAT-077-Intraperitoneal activation of blood coagulation via tissue factor-exposing extracellular vesicles in patients with advanced chronic liver disease (2019) (0)
Response to Letter to the Editor: Etiology and coagulation should be considered more. (2021) (0)
Etiology-specific hemostatic profiles in cirrhosis (2018) (0)
Reply to: plasma levels of cell-free DNA and the association with activation of coagulation prior to and during liver transplantation (2020) (0)
INCREASED DEVELOPMENT OF MICROTHROMBI AND FIBRIN DEPOSITIONS IN DECEASED DONOR KIDNEY TRANSPLANTATION (2020) (0)
P26 Circulating markers of neutrophil extracellular traps are associated with excessive coagulation activation in decompensated cirrhosis and acute-on-chronic liver failure (2022) (0)
Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assays (2023) (0)
Chapter 5: No increased systemic fibrinolysis in women with heavy menstrual bleeding (2018) (0)
University of Groningen Plasma from Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin (ART-123) Burlage, (2019) (0)
Controlled DCD Liver Transplantation Is Not Associated With Increased Hyperfibrinolysis and Blood Loss After Graft Reperfusion (2021) (0)
Risk factors for thrombosis and bleeding in pediatric liver transplantation in an Era of routine postoperative antithrombotic therapy (2019) (0)
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension. (2023) (0)
PFA-100 als Marker der primären Hämostase steht in keinem Zusammenhang mit Dekompensation/Mortalität oder Blutungen/Thrombosen bei Patienten mit fortgeschrittener chronischer Lebererkrankung (2022) (0)
The Clinical Relevance of Serum Gamma Glutamyl Transpeptidase in Liver Transplant Recipients (2012) (0)
The influence of lower-leg injury and knee arthroscopy on natural anticoagulants and fibrinolysis. (2022) (0)
Hemostatic balance in acute‐on‐chronic liver failure (2021) (0)
Reply (2020) (0)
Removal of destructive brain-borne microdust. (2018) (0)
From laboratory tests of coagulation to prognostic biomarkers in advanced chronic liver disease. (2023) (0)
The ISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration. (2023) (0)
Faculty Opinions recommendation of Factor XIII activity mediates red blood cell retention in venous thrombi. (2014) (0)
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy (2023) (0)
Injury of Peribiliary Glands of Donor Liver Bile Ducts Plays a Pivotal Role in the Development of Non-anastomotic Biliary Strictures after Liver Transplantation (2014) (0)
823 Activation of the Hedgehog Signal Transduction Pathway During the Development of Biliary Atresia in a Mouse Model (2009) (0)
PS-085-The impact of ABO blood group on von Willebrand factor levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease (2019) (0)
Reply (2019) (0)
Faculty Opinions recommendation of The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. (2011) (0)
CC CHEMOKINE RECEPTOR 5delta32 POLYMORPHISM IS NOT A RISK FACTOR DEVELOPMENT OF BILIARY STRICTURES AFTER LIVER TRANSPLANTATION, BUT IT IS ASSOCIATED WITH OVERALL SURVIVAL (2009) (0)
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: last call to harmonize criteria for future studies on promising associations. (2023) (0)
Histology of livers after 6 hours of normothermic machine perfusion. (2014) (0)
University of Groningen Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death (2014) (0)
Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites (2019) (0)
Comment to “Antithrombin III administration for portal vein thrombosis in patients with liver disease: A randomized double‐blind controlled trial” (2018) (0)
Faculty Opinions recommendation of FVIIa as used pharmacologically is not TF dependent in hemophilia B mice. (2014) (0)
Chemotherapy-induced hypercoagulability and biomarkers for prediction of thromboembolic events in patients with metastatic testicular cancer (2013) (0)
Does the Liver Determine Steady-State Circulating Blood Platelet Count in an Individual? A Multicenter Study in Deceased and Living Donor Liver Transplant Recipients (2012) (0)
Crosslinked clots formed independently of factor XIII and without fibrinogen‐to‐fibrin conversion – is this a liver‐specific phenomenon? (2018) (0)
thrombosis Reduced plasma fibrinolytic potential is a risk factor for venous (2013) (0)
Biliary pH, Bicarbonate and Glucose Are Suitable Biomarkers of Bile Duct Viability during Normothermic Machine Perfusion of Human Donor Livers. (2018) (0)
The VWF/ADAMTS13 unbalance, but not global coagulation or fibrinolytic status, is associated with outcome and bleeding in patients with acute liver failure (2020) (0)
FACTOR V LEIDEN MUTATION IS ASSOCIATED WITH HEPATIC ARTERY THROMBOSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION (2009) (0)
REGENERATION OF THE HUMAN EXTRAHEPATIC BILE DUCT AND THE ROLE OF PROGENITOR CELLS. (2009) (0)
Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease (2021) (0)
Identification of the von Willebrand Factor Binding Site in Collagen Using Triple Helical Peptides. (2005) (0)
University of Groningen Hemostasis and anticoagulant therapy in liver diseases (2017) (0)
Faculty Opinions recommendation of Hepatocyte tissue factor activates the coagulation cascade in mice. (2013) (0)
A hypercoagulable state does not play a major role in the development of portal vein thrombosis in patients with cirrhosis (2020) (0)
The international normalized ratio – Great for prediction of bleeding in patients taking vitamin K antagonists, useless for prediction of bleeding in patients with chronic liver disease (2022) (0)
Oxygenated hypothermic machine perfusion improves bile output and bile composition of extended criteria donor livers (2016) (0)
Histological Injury Detected in Biopsies of Extrahepatic Bile Duct of Donor Livers Represents Injury in the Rest of the Biliary Tree, Including the Intrahepatic Bile Ducts (2014) (0)
"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study": reply. (2023) (0)
In vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation. (2023) (0)
Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report. (2015) (0)
Hepatic Artery Diseases (2011) (0)
Response to cautious use of platelet as relevant inducer of liver regeneration following partial hepatectomy in patients with metastatic hepatic carcinoma (2017) (0)
Faculty Opinions recommendation of Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis. (2012) (0)
The 5 th International Symposium on Critical Bleeding (2015) (0)
Faculty Opinions recommendation of Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. (2013) (0)
University of Groningen Production of Physiologically Relevant Quantities of Hemostatic Proteins During Ex Situ Normothermic Machine Perfusion of Human Livers Karangwa, (2018) (0)
On coagulation in advanced chronic liver disease and the origin of freshwater eels. (2022) (0)
Duct-to-Duct Biliary Reconstruction in Liver Transplantation for Primary Sclerosing Cholangitis Is Associated with Less Biliary Complications, Compared with Roux-en-Y Hepatico-Jejunostomy. (2013) (0)
How to assess hemostatic capacity in patients with cirrhosis ? (2016) (0)
Hypothermic Oxygenated Dual Machine Perfusion after Cold Preservation Improves Viability and Hepatobiliary Function of Human Donor Livers by Restoring ATP content (2014) (0)
CHAPTER 6 Normothermic Machine Perfusion Reduces Bile Duct Injury and Improves Biliary Epithelial Function in Rat Donor Livers Liver Transpl (2019) (0)
The Authors' Reply to Letter to the Editor, Re: Biliary Bicarbonate, pH and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers. (2019) (0)
Faculty Opinions recommendation of Platelets and platelet-like particles mediate intercellular RNA transfer. (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ton Lisman?

Ton Lisman is affiliated with the following schools:

Ton Lisman's Academic­Influence.com Rankings

Ton Lisman's Degrees

Similar Degrees You Can Earn

Why Is Ton Lisman Influential?

Ton Lisman's Published Works

Published Works

What Schools Are Affiliated With Ton Lisman?

Ton Lisman's AcademicInfluence.com Rankings